MEDNAX Inc
NYSE:MD
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
6.77
16.08
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
MEDNAX Inc
MEDNAX Inc
Cash from Financing Activities
MEDNAX Inc
Cash from Financing Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
MEDNAX Inc
NYSE:MD
|
Cash from Financing Activities
-$14.3m
|
CAGR 3-Years
73%
|
CAGR 5-Years
42%
|
CAGR 10-Years
N/A
|
|
|
DaVita Inc
NYSE:DVA
|
Cash from Financing Activities
-$655.1m
|
CAGR 3-Years
5%
|
CAGR 5-Years
31%
|
CAGR 10-Years
-13%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Cash from Financing Activities
$1.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
21%
|
|
|
CVS Health Corp
NYSE:CVS
|
Cash from Financing Activities
-$2.5B
|
CAGR 3-Years
40%
|
CAGR 5-Years
11%
|
CAGR 10-Years
1%
|
|
|
Cigna Corp
NYSE:CI
|
Cash from Financing Activities
-$5.6B
|
CAGR 3-Years
19%
|
CAGR 5-Years
-39%
|
CAGR 10-Years
-15%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Cash from Financing Activities
$880.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
MEDNAX Inc
Glance View
MEDNAX, Inc. engages in the provision of physician services. The company is headquartered in Sunrise, Florida and currently employs 2,725 full-time employees. The firm provides neonatal care, which provides clinical care to babies born prematurely or with complications within specific units at hospitals, primarily neonatal intensive care units (NICUs), through its network of affiliated neonatal physician subspecialists (neonatologists), neonatal nurse practitioners and other pediatric clinicians. The company offers maternal-fetal care, which provides inpatient and office-based clinical care to expectant mothers and their unborn babies through its affiliated maternal-fetal medicine subspecialists as well as obstetricians and other clinicians, such as maternal-fetal nurse practitioners and certified nurse mid-wives. The company provides other pediatric subspecialty care services, which includes other pediatric subspecialists, such as, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists.
See Also
What is MEDNAX Inc's Cash from Financing Activities?
Cash from Financing Activities
-14.3m
USD
Based on the financial report for Sep 30, 2024, MEDNAX Inc's Cash from Financing Activities amounts to -14.3m USD.
What is MEDNAX Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
42%
Over the last year, the Cash from Financing Activities growth was 87%. The average annual Cash from Financing Activities growth rates for MEDNAX Inc have been 73% over the past three years , 42% over the past five years .
You don't have any saved screeners yet
